Dividend Growth of Sanofi(SNY)

Sanofi(SNY) is having a Dividend Yield of 2.59% with the Annual cash Dividend per share of $1.12. Sanofi has a 5 year average dividend yield of 2.76% and the stock has a Indicated annual dividend of $1.12. Sanofi(SNY) formally announced its most recent dividend on May 26, 2016 with a Dividend per share of $1.12. The new indicated annual dividend based on announced dividend per share is $1.12. The dividend yield based on the forward looking indicated annual dividend is 2.59%. Sanofi(SNY) has the most recent dividend payout ratio of 0.36 with a 5-year average payout ratio of 0.36. The 5 year historical dividend growth of Sanofi(SNY) is at the rate of -5.82% while the R-Squared dividend growth is 0.73. If the value of R-Square is close to one, it indicates a perfect fit and the higher value conforms to the regression line while data close to zero indicates the opposite.

Sanofi (NYSE:SNY) rose 0.44% or 0.19 points on Thursday and made its way into the gainers of the day. After trading began at $43.6 the stock was seen hitting $43.7198 as a peak level and $43.405 as the lowest level. The stock ended up at $43.54. The daily volume was measured at 962,489 shares. The 52-week high of the share price is $44.5 and the 52-week low is $36.8101. The company has a market cap of $112,081 million. Shares of Sanofi rose by 1.97% in the last five trading days and 6.82% for the last 4 weeks. Sanofi is up 4.94% in the last 3-month period. Year-to-Date the stock performance stands at 7.67%.

Currently the company Insiders own 1% of Sanofi shares according to the proxy statements. Institutional Investors own 9.63% of Sanofi shares. Sanofi SA (ADR) Last issued its quarterly earnings results on Feb 8, 2017. The company reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $1.23. The company had revenue of $8876.00 million for the quarter, compared to analysts expectations of $9233.20 million. The companys revenue was down -4.3 % compared to the same quarter last year.

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.


Share this post

Leave a Reply